Evidence map›Paper›PMID 27796754›Full record

ArticleMolecular neurobiology2017

Ketamine Self-Administration Reduces the Homeostasis of the Glutamate Synapse in the Rat Brain.

Lucia Caffino, Alessandro Piva, Giuseppe Giannotti, Marzia Di Chio, Francesca Mottarlini, Marco Venniro, David T Yew, Cristiano Chiamulera, Fabio Fumagalli

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Lucia CaffinoDipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Via Balzaretti 9, 20133, Milan, Italy.
Alessandro PivaNeuropsychopharmacology Lab, Section Pharmacology, Department Diagnostic & Public Health, University of Verona, P.le Scuro 10, Verona, Italy.
Giuseppe GiannottiDipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Via Balzaretti 9, 20133, Milan, Italy.
Marzia Di ChioNeuropsychopharmacology Lab, Section Pharmacology, Department Diagnostic & Public Health, University of Verona, P.le Scuro 10, Verona, Italy.
Francesca MottarliniDipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Via Balzaretti 9, 20133, Milan, Italy.
Marco VenniroNeuropsychopharmacology Lab, Section Pharmacology, Department Diagnostic & Public Health, University of Verona, P.le Scuro 10, Verona, Italy.
David T YewBrain Research Centre, School of Biomedical Science, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, N.T, Hong Kong.
Cristiano ChiamuleraNeuropsychopharmacology Lab, Section Pharmacology, Department Diagnostic & Public Health, University of Verona, P.le Scuro 10, Verona, Italy.
Fabio FumagalliDipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Via Balzaretti 9, 20133, Milan, Italy. Fabio.Fumagalli@unimi.it.ORCID http://orcid.org/0000-0002-8814-7706
University of Milan · ITUniversity of Verona · ITChinese University of Hong Kong · HK

Funding

Sostanze d'abuso Fondazione Zardi Gori
6 · The paper itself

Abstract

Ketamine is a non-competitive antagonist of the NMDA glutamate receptor with psychotomimetic and reinforcing properties, although recent work has pointed out its antidepressant action following acute exposure. Our aim was to investigate the expression of crucial components of the glutamate synapse following chronic ketamine self-administration (S/A), focusing our attention on medial prefrontal cortex (mPFC) and hippocampus (Hip), two brain regions involved in compulsive drug-seeking and drug-related cognitive disorders. Rats self-administered ketamine at a sub-anesthetic dose for 5-6 weeks and were sacrificed 24 h after the last drug exposure. We found a general downregulation of glutamate receptor expression that was brain region-dependent. In fact, in the mPFC, we found reduced expression of NMDA receptor subunits, whereas AMPA receptor protein levels were reduced in Hip; of note, specific scaffolding proteins of NMDA and AMPA receptors were also reduced in mPFC and Hip, respectively. Moreover, the metabotropic mGluR5 receptor was similarly downregulated in these brain regions. These findings reveal a dynamic impairment of glutamate homeostasis in the mPFC and Hip that may represent a signature of long-term exposure to ketamine S/A. Further, this decrement, similarly observed in humans and animal models of schizophrenia may represent a specific feature of the human disease endophenotype.

Indexed as

AnimalsBrainExcitatory Amino Acid AntagonistsGlutamic AcidHomeostasisKetamineMaleRatsRats, Sprague-DawleyReceptor, Metabotropic Glutamate 5Receptors, N-Methyl-D-AspartateSelf AdministrationSynapsesExcitatory Amino Acid AntagonistsGlutamic AcidGrm5 protein, ratKetamineReceptor, Metabotropic Glutamate 5Receptors, N-Methyl-D-AspartateAMPA receptorsglutamateKetamineMetabotropic receptorsNMDA receptorsSchizophrenia

Identifiers

PMID27796754
OpenAlexW2539966020

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.